SEP
JNJ icon

Signature Equity Partners’s Johnson & Johnson JNJ Stock Holding History

Signature Equity Partners’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$514K Sell
2,026
-329
-14% -$76.7K 0.24% 91
2026
Q1 		$576K Buy
2,355
+115
+5% +$26.8K 0.31% 71
2025
Q4 		$464K Buy
+2,240
New +$443K 0.26% 90

Other funds holding JNJ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Signature Equity Partners's JNJ Position: Q2 2026 in Review

Signature Equity Partners reduced its Johnson & Johnson (JNJ) stake by 14% in Q2 2026, selling an estimated $76.7K and leaving 2,026 shares worth $514K. The position accounts for 0.24% of the portfolio, ranked #91.

Signature Equity Partners first reported a position in JNJ in Q4 2025 and has held it in 3 quarters since. The position peaked at $576K in Q1 2026. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Signature Equity Partners held 2,026 shares of Johnson & Johnson worth $514K as of Q2 2026.
  • Signature Equity Partners sold 329 Johnson & Johnson shares in Q2 2026, an estimated $76.7K.
  • Johnson & Johnson made up 0.24% of Signature Equity Partners's portfolio in Q2 2026, its #91 holding.
  • Signature Equity Partners first reported a position in Johnson & Johnson in Q4 2025 and has held it in 3 quarters since.
  • Signature Equity Partners's Johnson & Johnson position peaked at $576K in Q1 2026.
  • 4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.